B-CELL LYMPHOMA
Clinical trials for B-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new B-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for B-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New CAR-T therapy shows promise in early trial for Hard-to-Treat lymphoma
Disease control TerminatedThis early-stage study tested a new treatment called ASP2802 for people with B-cell lymphoma that came back or stopped responding to other treatments. The therapy uses a patient's own immune cells, which are modified in a lab to better fight cancer, and then given back along with…
Matched conditions: B-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated May 26, 2026 11:08 UTC
-
Gene-Edited immune cells take on Hard-to-Treat blood cancers
Disease control TerminatedThis study tested a new treatment called CTX110, which uses CRISPR gene editing to modify donor immune cells to attack cancer. It was for adults with B-cell cancers like non-Hodgkin lymphoma or B-cell acute lymphoblastic leukemia that had come back or not responded to other treat…
Matched conditions: B-CELL LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: CRISPR Therapeutics AG • Aim: Disease control
Last updated May 26, 2026 10:35 UTC